A phaseII study of nab-paclitaxef in patients with pretreated advanced non-small-cell lung cancer.
Phase 2
- Conditions
- on-Small-Cell Lung Cancer
- Registration Number
- JPRN-UMIN000014202
- Lead Sponsor
- Kansai Medical University Hirakata Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)With severe myelosupression. 2) With active infectious disease 3) Interstitial pneumonia or pulmonary fibrosis detectable on X ray 4)History of cardiac dysfunction 5)History of treatment with paclitaxel. 6)History of albumin sensitivity 7)Symptomatic brain metastasis 8)Pericardial or pleural effusion requiring drainage 9) History of serious disease condition 10) History of drug allergy 11) With pregnancy or lactation 12) Without measurable lesion by RECIST 13) With grade2 or more neuropathy 14) Evaluated to be ineligible by a physician for other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response Rate progression free survival
- Secondary Outcome Measures
Name Time Method Progression free survival, Overall Survival, Safety